Chemed's top three insider shareholders as of May 04, 2026 are Nicholas Michael Westfall (Executive Vice President, 7.68K shares), Thomas P Rice (Director, 6.03K shares), Michael D Witzeman (Vp Chief Financial Officer, 5.95K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Nicholas Michael Westfall | Executive Vice President | 7,676 | 0 | 05 Jun, 2023 |
| Thomas P Rice | - | 6,028 | 0 | 21 May, 2024 |
| Michael D Witzeman | Vp Chief Financial Officer | 5,953 | 0 | 17 Feb, 2026 |
| David Patrick Williams | Executive Vice President Cfo | 5,826 | 0 | 15 Nov, 2023 |
| Thomas P Rice | - | 5,744 | 0 | 16 May, 2023 |
| Donald E Saunders | - | 5,593 | 0 | 17 May, 2022 |
| George J Iii Walsh | - | 3,523 | 0 | 05 Aug, 2025 |
| George J Iii Walsh | - | 3,362 | 0 | 16 May, 2023 |
| Michael D Witzeman | Vice President And Controller | 2,984 | 0 | 08 Nov, 2023 |
| Brian C Judkins | Vp And Chief Legal Officer | 2,436 | 0 | 17 Feb, 2026 |
| Christopher J Heaney | - | 2,389 | 0 | 20 May, 2025 |
| Christopher J Heaney | - | 1,828 | 0 | 16 May, 2023 |
| Ron Delyons | - | 1,666 | 0 | 20 May, 2025 |
| Ron Delyons | - | 1,105 | 0 | 16 May, 2023 |
| John Meredith Jr. Mount | - | 930 | 0 | 20 May, 2025 |
| Eileen P Mccarthy | - | 855 | 0 | 20 May, 2025 |
| Joel L Wherley | Ceo Vitas Healthcare | 852 | 0 | 17 Feb, 2026 |
| Brian C Judkins | Vp And Chief Legal Officer | 475 | 0 | 22 Feb, 2023 |
| John Meredith Jr. Mount | - | 369 | 0 | 16 May, 2023 |
| Eileen P Mccarthy | - | 294 | 0 | 18 May, 2023 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 13 Feb, 2026 | Brian C Judkins | Capital Stock | A | 351 | $469.56 | 2,538 | D | M |
| 13 Feb, 2026 | Michael D Witzeman | Capital Stock | A | 413 | $469.56 | 6,073 | D | M |
| 13 Feb, 2026 | Joel L Wherley | Capital Stock | A | 273 | $469.56 | 932 | D | M |
| 13 Feb, 2026 | Joel L Wherley | Capital Stock | D | 80 | $469.56 | 852 | D | F |
| 13 Feb, 2026 | Michael D Witzeman | Capital Stock | D | 120 | $469.56 | 5,953 | D | F |
| 13 Feb, 2026 | Brian C Judkins | Capital Stock | D | 102 | $469.56 | 2,436 | D | F |
| 13 Feb, 2026 | Michael D Witzeman | Performance Stock Units | D | 333 | $0.00 | 2,403 | D | M |
| 13 Feb, 2026 | Joel L Wherley | Performance Stock Units | D | 220 | $0.00 | 1,290 | D | M |
| 13 Feb, 2026 | Brian C Judkins | Performance Stock Units | D | 283 | $0.00 | 1,681 | D | M |
| 13 Feb, 2026 | Michael D Witzeman | Performance Stock Units | D | 333 | $0.00 | 2,070 | D | M |
| 13 Feb, 2026 | Brian C Judkins | Performance Stock Units | D | 283 | $0.00 | 1,398 | D | M |
| 13 Feb, 2026 | Joel L Wherley | Performance Stock Units | D | 220 | $0.00 | 1,070 | D | M |
| 13 Feb, 2026 | Michael D Witzeman | Performance Stock Units | A | 1,394 | $0.00 | 3,464 | D | A |
| 13 Feb, 2026 | Brian C Judkins | Performance Stock Units | A | 908 | $0.00 | 2,306 | D | A |
| 13 Feb, 2026 | Joel L Wherley | Performance Stock Units | A | 1,142 | $0.00 | 2,212 | D | A |
| 21 Oct, 2025 | Brian C Judkins | Stock Option (right to buy with tandem tax withholding) | A | 15,017 | $443.79 | 38,067 | D | A |
| 21 Oct, 2025 | Michael D Witzeman | Stock Option (right to buy with tandem tax withholding) | A | 19,486 | $443.79 | 53,970 | D | A |
| 21 Oct, 2025 | Joel L Wherley | Stock Option (right to buy with tandem tax withholding) | A | 17,476 | $443.79 | 32,819 | D | A |
| 04 Aug, 2025 | George J Iii Walsh | Capital Stock | A | 200 | $417.10 | 3,523 | D | P |
| 04 Aug, 2025 | Nicholas Michael Westfall | Capital Stock | D | 10,012 | $421.91 | 0 | D | S |